Found 8 matching trials
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension
PHASE2This clinical trial is a study to evaluate the safety, tolerability, and ch...
Location
Radboud University Medical Center
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
PHASE3This is a study to evaluate the safety and efficacy of losmapimod in treati...
Location
University of California Irvine
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
PHASE2This study is being conducted to assess the potential anti-inflammatory eff...
Location
GSK Investigational Site
A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin
PHASE1This will be a double-blind, 4-period, randomized, cross-over study conduct...
Location
GSK Investigational Site
PK Study of IV Formulation of GW856553
PHASE1The purpose of this study is to evaluate the safety of an IV infusion of GW...
Location
GSK Investigational Site
Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets
PHASE1This is a study to assess the relative bioavailability and the effect of fo...
Location
PPD Phase I Clinic
Phase I Study of GW856553 (Losmapimod)
PHASE1This study is the first study of losmapimod in Japanese subjects. This stud...
Location
GSK Investigational Site
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
PHASE2This is a single-arm, multicenter, open-label Phase II, proof-of-mechanism ...
Location
GSK Investigational Site